Why Compare Mounjaro V Wegovy Through Private Prescription?
Private Prescription Advantages: Mounjaro V Wegovy Access
The NHS route for accessing either Mounjaro or Wegovy typically requires a GP referral to specialist weight management services, followed by waiting periods that can extend beyond six months. Private prescription eliminates these barriers entirely, allowing you to compare Mounjaro v Wegovy options through direct clinical assessment. EverydayMeds' GPhC-registered service (#9012878) provides both medications without requiring existing NHS referrals or specialist appointments. Your prescriber can evaluate which treatment aligns with your medical history, lifestyle preferences, and weight management goals during the same consultation process.
The private route also ensures consistent supply availability, addressing the intermittent shortages that have affected NHS prescribing of these medications. When comparing Mounjaro v Wegovy privately, you gain immediate access to detailed prescriber guidance about each medication's unique characteristics. This includes understanding Wegovy's GLP-1-only mechanism versus Mounjaro's dual GIP and GLP-1 receptor approach. Private prescription allows for flexible treatment switching if your initial choice requires adjustment, without returning to lengthy NHS approval processes.
Pricing Structure: Mounjaro V Wegovy Cost Comparison
Wegovy follows a structured five-dose escalation schedule starting at £79.99 for the 0.25mg starter dose when using code FIRST40 at checkout. The progression moves through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), reaching the maintenance 2.4mg dose at £209.99. Returning customers benefit from code DOSE25 for continued treatment. Bundle options like the Intro Duo (0.25mg & 0.5mg) at £169.99 provide convenient two-month starter packages. The Ultimate Stability Trio offers three months of maintenance 2.4mg supply for £649.99, ensuring treatment continuity.
Mounjaro pricing follows its own tiered structure, reflecting the medication's different manufacturing and licensing costs. When evaluating Mounjaro v Wegovy expenses, consider the total treatment duration and maintenance requirements alongside initial costs. Both medications require ongoing prescription oversight, included within EverydayMeds' clinical service. The private prescription model provides transparent, upfront pricing without hidden NHS prescription charges or specialist consultation fees that can accumulate over time.
Clinical Evidence Base: Mounjaro V Wegovy Research
Wegovy's efficacy stems from the landmark STEP trial programme, with STEP 1 demonstrating approximately 15% average weight loss at 68 weeks when combined with lifestyle interventions, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP trials enrolled diverse patient populations across BMI ranges, providing robust evidence for Wegovy's prescription-only medicine status. Recent SELECT cardiovascular outcomes data showed 20% reduction in major cardiovascular events, expanding the evidence base beyond weight management alone.
Mounjaro's clinical foundation rests on the SURMOUNT trial series, investigating tirzepatide's dual receptor mechanism in weight management contexts. When comparing Mounjaro v Wegovy research, both demonstrate significant efficacy versus placebo, though direct head-to-head comparison studies remain limited. Individual response varies considerably, making prescriber evaluation crucial for determining which medication may provide optimal outcomes for your specific circumstances.
Wegovy Mechanism: How GLP-1 Receptor Agonism Works
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone GLP-1 released after eating. This mechanism targets appetite regulation centres in the brain, promoting feelings of fullness and satisfaction with smaller meal portions. The medication may also slow gastric emptying, extending the duration of post-meal satiety signals. Weekly injection maintains consistent blood levels, supporting sustained appetite modulation throughout treatment. Clinical assessment determines whether Wegovy's single-receptor approach aligns with your weight management requirements when comparing Mounjaro v Wegovy options.
Streamlined Ordering: Mounjaro V Wegovy Prescription Process
EverydayMeds' 3-minute online assessment covers medical history, current medications, and treatment preferences relevant to both Mounjaro and Wegovy prescribing. Our qualified prescribers review applications within three working days (24-hour express option available), evaluating suitability for either medication based on MHRA licensing criteria. Once approved, both treatments ship via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements throughout transport. The streamlined process eliminates traditional pharmacy visits while ensuring full clinical oversight. Whether you're considering Mounjaro v Wegovy, the same rigorous assessment applies, with prescriber guidance helping determine the most appropriate choice.
Storage and Practical Considerations: Mounjaro V Wegovy Handling
Both medications require refrigerated storage at 2-8°C before first use, but Wegovy offers superior travel flexibility with 6 weeks room temperature stability once removed from the fridge. Mounjaro maintains room temperature stability for 21 days, still practical for most travel scenarios but requiring more careful planning. Wegovy's FlexTouch pen system provides clear dose indication and user-friendly injection mechanics. The mandatory dose escalation schedule prevents starting at higher strengths, ensuring gradual tolerance development. When weighing Mounjaro v Wegovy practicalities, consider your lifestyle demands, travel frequency, and comfort with the specific injection systems each medication employs.
Private Treatment Flexibility: Mounjaro V Wegovy Switching Options
Private prescription allows treatment modification based on individual response patterns, side effect profiles, or changing clinical circumstances. If initial Mounjaro response proves suboptimal, switching to Wegovy requires only prescriber consultation rather than complete NHS re-referral processes. Similarly, patients beginning with Wegovy can transition to Mounjaro if clinical assessment suggests potential benefits from the dual receptor mechanism. This flexibility represents a key advantage when comparing Mounjaro v Wegovy through private versus NHS routes.
Treatment gaps due to supply issues, travel requirements, or temporary contraindications can be managed more responsively through private prescription. Your prescriber maintains detailed records enabling smooth treatment resumption or alternative medication initiation. The ability to access both Mounjaro and Wegovy from the same pharmacy ensures consistent clinical oversight regardless of which treatment proves most suitable for your long-term weight management strategy.
Making Your Decision: Complete Mounjaro V Wegovy Support
EverydayMeds provides comprehensive support for both Mounjaro and Wegovy patients, from initial prescription through maintenance treatment phases. Our clinical team understands the nuances of each medication, offering guidance on managing side effects, optimising injection techniques, and maintaining treatment adherence. Whether you choose Mounjaro's dual mechanism or Wegovy's established GLP-1 approach, the same clinical standards apply. Remember that both medications work alongside reduced-calorie diet and increased physical activity for optimal outcomes. Start your comparison today using code FIRST40 for new customers or DOSE25 for returning patients at https://everydaymeds.co.uk/collections/wegovy, where our prescribers can help determine which treatment aligns with your weight management goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
